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Backgruond. Three-dimensional conformal radiotherapy (3D-CRT) in the planning treatment of locorregional breast cancer includ-
ing the internal mammary chain is realized, in our centre, by using tangential ﬁelds with multisegments; and PA-AP ﬁelds for
nodal areas. Helical Tomotherapy (HT) is a sort of intensity-modulated radiation therapy, that uses an integrated CT scanner
during radiation which is performed helicoidally.
Purpose. To compare the dosimetric distribution of two breast radiotherapy plans: three-dimensional conformal radiotherapy vs.
Helical Tomotherapy.
Methods and materials. Six patients with stage IIIC breast cancer affecting internal mammary chain (clinically and/or histologically
conﬁrmed), were included in this study. For each patient, treatment plans were generated to compare the three-dimensional con-
formal radiotherapy (3D-CRT) against the Helical Tomotherapy (HT). CT simulation was performed in supine position with both
arms above head and external rotation. The planning target volumes (PTV) included the chest wall/whole breast, supraclavicular,
axillary, and internal mammary chain nodes. Dose prescription was 50.4Gy, in 28 fractions of 1.8Gy, to the PTV.
Results. The average V20 and V5 for heart was 7.28% and 84.94% for HT vs. 2.73% and 8.18% for 3D-CRT. The average V30, V20 and
V5 for ipsilateral lung was 19.66%, 31.47% and 92.61% for HT vs. 33.78%, 38.41% and 54.82% for 3D-CRT. The average percentage
of the contralateral lung receiving ≥5Gy was 62.41% for HT and 2.86% for 3D-CRT. The average percentage of the contralateral
breast receiving ≥5Gy was 50.33% for HT and 8.18% for 3D-CRT.
Conclusion. Tomotherapy decreases high dose irradiation in lung at the expense of a greater volume of lung and heart receiving
low-dose irradiation and higher irradiation of contralateral breast and lung. The choice of treatment plan must be individualized
for each patient based on doses in heart, and contralateral breast and lung.
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Background. Despite the fact that electronic health records are currently more and more common, not all the information
contained can be used in automatic process.
Aim. The objective of this study is to identify automatically the tumor size from the pathology reports before adjuvant radiation
therapy for breast cancer.
Methods. Sixty-eight pathology reports of patients with breast cancer treated with adjuvant radiation therapy between January
and April 2012 were used as a test dataset and 89 pathology reports from a different hospital were used as a validation set.
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